Table 1 (abstract P96). Patient‑reported outcome (PRO) measures in patients with migraine who experience ≥4 migraine headache days/month and <4 migraine headache days/month in the US and in five European countries
| Â | US Population | 5-EU Population | ||
|---|---|---|---|---|
≥4 MHDs/ month | < 4 MHDs/ month | ≥4 MHDs/ month | < 4 MHDs/ month | |
(n=584) | (n=789) | (n=1942) | (n=2147) | |
Disability Category by MIDAS Value, n (%) | ||||
 Little/No | 102 (41.5) | 291 (69.5) | 247 (35.2) | 477 (56.4) |
 Mild | 57 (23.2) | 62 (14.8) | 127 (18.1) | 150 (17.8) |
 Moderate | 40 (16.3) | 44 (10.5) | 182 (26.0) | 127 (15.0) |
 Severe | 30 (12.2) | 18 ( 4.3) | 101 (14.4) | 77 ( 9.1) |
 Very severe | 17 ( 6.9) | 4 ( 1.0) | 44 ( 6.3) | 14 ( 1.7) |
MSQ Domain, Mean (SD) | ||||
 Total | 67.6 (21.2) | 78.8 (19.1) | 67.7 (18.6) | 76.1 (17.4) |
 Role Function: Restrictive | 63 (21.3) | 75.6 (19.4) | 64.2 (19.6) | 72.4 (18.6) |
 Role Function: Preventive | 73.5 (21.9) | 82.1 (20) | 72.3 (19.8) | 79.9 (17.9) |
 Emotional | 70.2 (24.9) | 82 (22) | 69.9 (21.8) | 79.7 (19.8) |
WPAI, Mean (SD) | ||||
 % work time missed due to problem | 10.4 (22.8) | 5.2 (18.1) | 10 (21.4) | 4 (13.7) |
 % impairment while working due to problem | 36.5 (28.3) | 21.7 (24.1) | 34.5 (22.5) | 21.9 (22) |
 % overall work impairment due to problem | 40.3 (29.6) | 22.7 (24.7) | 39.7 (24.2) | 23.4 (23.2) |
 % activity impairment due to problem | 38.6 (27.4) | 25.3 (24.8) | 39 (23.4) | 27.7 (24) |
EQ-5D-5L, Mean (SD) | ||||
 EQ5D Utility Score | 0.9 (0.1) | 0.9 (0.1) | 0.8 (0.2) | 0.9 (0.2) |
 EQ5D Visual Analogue Scale | 79.8 (14.7) | 84.3 (13) | 74.8 (15.8) | 80.2 (15.4) |